Valproate In The Spotlight As EMA Releases Date For First Ever Public Hearing

The European Medicines Agency has released the date for its public hearing on valproate in which EU citizens will for the first time be given a voice in evaluating the safety of medicines on the market.

Speaker's microphone in seminar meeting room
The EMA will be holding its first public hearing in September • Source: Shutterstock

The European Medicines Agency will hold its first ever public hearing on the safety of marketed medicines on Sept. 26 to review the use of valproate-containing medicines in the treatment of women and girls who are pregnant or of childbearing age.

The public hearing, to be held by the EMA’s Pharmacovigilance Risk Assessment Committee, will mark the first time that EU...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography